Translator Disclaimer
1 June 2005 Doxycycline-Medicated Drinking Water for Treatment of Chlamydophila psittaci in Exotic Doves
Author Affiliations +
Abstract

Chlamydophila psittaci was identified by polymerase chain reaction (PCR) testing of choano–cloacal combination swabs collected from 9 of 15 fruit doves of different species. These birds were housed in close proximity to other individuals, and all birds were considered exposed to C psittaci infection. Group treatment was initiated by offering doxycycline hyclate in drinking water at 0.5 g/L for 45 days. During the treatment period, 18 fruit doves representing 4 species (including 5 birds that tested positive for C psittaci) were observed daily and weighed and examined weekly. Plasma doxycycline concentrations in these birds were measured at treatment days 3, 8, 14, 21, 35, and 42. Lacrimo–choanal–cloacal combination swabs were collected for C psittaci PCR testing at 5, 10, and 15 days after treatment ended. No adverse effects of treatment were observed. Mean plasma doxycycline concentration for all samples was 1.56 ± 1.3 μg/ml. After treatment, all 18 selected birds tested negative for C psittaci. Also, C psittaci was not detected in 49 additional lacrimo–choanal– cloacal combination swabs collected from the larger group of exposed birds during a 6-month period after treatment. The results of this study suggest that doxycycline-medicated drinking water may offer a safe, inexpensive, and practical method to treat fruit doves infected with C psittaci.

Luis R. Padilla, Keven Flammer, and R. Eric Miller "Doxycycline-Medicated Drinking Water for Treatment of Chlamydophila psittaci in Exotic Doves," Journal of Avian Medicine and Surgery 19(2), 88-91, (1 June 2005). https://doi.org/10.1647/2003-034
Published: 1 June 2005
JOURNAL ARTICLE
4 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top